203 related articles for article (PubMed ID: 17150163)
1. Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion.
Matthews QL; Sibley DA; Wu H; Li J; Stoff-Khalili MA; Waehler R; Mathis JM; Curiel DT
Mol Imaging; 2006; 5(4):510-9. PubMed ID: 17150163
[TBL] [Abstract][Full Text] [Related]
2. Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion.
Li J; Le L; Sibley DA; Mathis JM; Curiel DT
Virology; 2005 Aug; 338(2):247-58. PubMed ID: 15996701
[TBL] [Abstract][Full Text] [Related]
3. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects.
Ray P; Tsien R; Gambhir SS
Cancer Res; 2007 Apr; 67(7):3085-93. PubMed ID: 17409415
[TBL] [Abstract][Full Text] [Related]
4. Derivation of a triple mosaic adenovirus for cancer gene therapy.
Tang Y; Wu H; Ugai H; Matthews QL; Curiel DT
PLoS One; 2009 Dec; 4(12):e8526. PubMed ID: 20046872
[TBL] [Abstract][Full Text] [Related]
5. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.
Campos SK; Parrott MB; Barry MA
Mol Ther; 2004 Jun; 9(6):942-54. PubMed ID: 15194061
[TBL] [Abstract][Full Text] [Related]
6. Genetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imaging.
Mathis JM; Bhatia S; Khandelwal A; Kovesdi I; Lokitz SJ; Odaka Y; Takalkar AM; Terry T; Curiel DT
PLoS One; 2011 Feb; 6(2):e16792. PubMed ID: 21347423
[TBL] [Abstract][Full Text] [Related]
7. Use of adenovirus protein IX (pIX) to display large polypeptides on the virion--generation of fluorescent virus through the incorporation of pIX-GFP.
Meulenbroek RA; Sargent KL; Lunde J; Jasmin BJ; Parks RJ
Mol Ther; 2004 Apr; 9(4):617-24. PubMed ID: 15093192
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase.
Mizuguchi H; Hayakawa T
Cancer Gene Ther; 2002 Mar; 9(3):236-42. PubMed ID: 11896439
[TBL] [Abstract][Full Text] [Related]
9. Bovine adenovirus type 3 containing heterologous protein in the C-terminus of minor capsid protein IX.
Zakhartchouk A; Connors W; van Kessel A; Tikoo SK
Virology; 2004 Mar; 320(2):291-300. PubMed ID: 15016551
[TBL] [Abstract][Full Text] [Related]
10. Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX.
Vellinga J; Rabelink MJ; Cramer SJ; van den Wollenberg DJ; Van der Meulen H; Leppard KN; Fallaux FJ; Hoeben RC
J Virol; 2004 Apr; 78(7):3470-9. PubMed ID: 15016870
[TBL] [Abstract][Full Text] [Related]
11. A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeutics.
Puntel M; Muhammad AK; Candolfi M; Salem A; Yagiz K; Farrokhi C; Kroeger KM; Xiong W; Curtin JF; Liu C; Bondale NS; Lerner J; Pechnick RN; Palmer D; Ng P; Lowenstein PR; Castro MG
J Virol; 2010 Jun; 84(12):6007-17. PubMed ID: 20375153
[TBL] [Abstract][Full Text] [Related]
12. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.
Xiong Z; Cheng Z; Zhang X; Patel M; Wu JC; Gambhir SS; Chen X
J Nucl Med; 2006 Jan; 47(1):130-9. PubMed ID: 16391197
[TBL] [Abstract][Full Text] [Related]
13. Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.
Poulin KL; Lanthier RM; Smith AC; Christou C; Risco Quiroz M; Powell KL; O'Meara RW; Kothary R; Lorimer IA; Parks RJ
J Virol; 2010 Oct; 84(19):10074-86. PubMed ID: 20631131
[TBL] [Abstract][Full Text] [Related]
14. Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma.
Jang SJ; Kang JH; Kim KI; Lee TS; Lee YJ; Lee KC; Woo KS; Chung WS; Kwon HC; Ryu CJ; Choi TH; Choi CW; Lim SM; Cheon GJ
Cancer Lett; 2010 Nov; 297(1):84-90. PubMed ID: 20819721
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.
Wildner O; Hoffmann D; Jogler C; Uberla K
Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus protein IX: a new look at an old protein.
Parks RJ
Mol Ther; 2005 Jan; 11(1):19-25. PubMed ID: 15585402
[TBL] [Abstract][Full Text] [Related]
17. Using [¹⁸F]FBAU for imaging brain tumor progression in an F98/tk-luc glioma-bearing rat model.
Chien YC; Chen JC; Lin WC; Ding HJ; Wang HE; Kao CH; Hwang JJ
Oncol Rep; 2014 Aug; 32(2):691-9. PubMed ID: 24926696
[TBL] [Abstract][Full Text] [Related]
18. Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX.
Tang Y; Le LP; Matthews QL; Han T; Wu H; Curiel DT
Virology; 2008 Aug; 377(2):391-400. PubMed ID: 18570971
[TBL] [Abstract][Full Text] [Related]
19. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
20. Fusion of Large Polypeptides to Human Adenovirus Type 5 Capsid Protein IX Can Compromise Virion Stability and DNA Packaging Capacity.
Poulin KL; McFall ER; Chan G; Provost NB; Christou C; Smith AC; Parks RJ
J Virol; 2020 Aug; 94(17):. PubMed ID: 32522855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
